A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : OPSCC / oropharyngeal squamous cell carcinoma

[Related PubMed/MEDLINE]
Total Number of Papers: 641
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   OPSCC  (>> Co-occurring Abbreviation)
Long Form:   oropharyngeal squamous cell carcinoma
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 A global epidemic increase of an HPV-induced tonsil and tongue base cancer - potential benefit from a pan-gender use of HPV vaccine. BOTSCC, HPV, TSCC
2020 A Phase 2 Trial of Alternative Volumes of Oropharyngeal Irradiation for De-intensification (AVOID): Omission of the Resected Primary Tumor Bed After Transoral Robotic Surgery for Human Papilloma Virus-Related Squamous Cell Carcinoma of the Oropharynx. AVOID, HPV, RT, TORS
2020 A proposal for classification of oropharyngeal squamous cell carcinoma: Morphology and status of HPV by immunohistochemistry and molecular biology. HNSCC, HPV
2020 A review of the 8th edition of the AJCC staging system for oropharyngeal cancer according to HPV status. HPV
2020 Anatomical subsite modifies survival in oropharyngeal squamous cell carcinoma: National Cancer Database study. HPV, NCDB, nTRA, TRA
2020 CD8 infiltration is associated with disease control and tobacco exposure in intermediate-risk oropharyngeal cancer. HPV, OS, RFS, TIME
2020 Childhood tonsillectomy alters the primary distribution of HPV-related oropharyngeal squamous cell carcinoma. HPV, MVA, OR, UVA
2020 Clinical characteristics and treatment outcome of oropharyngeal squamous cell carcinoma in an endemic betel quid region. ABC
2020 Comparison of Molecular Assays for HPV Testing in Oropharyngeal Squamous Cell Carcinomas: A Population-Based Study in Northern Ireland. HPV
10  2020 Concordance of tumor infiltrating lymphocytes, PD-L1 and p16 expression in small biopsies, resection and lymph node metastases of oropharyngeal squamous cell carcinoma. HPV, LN, TIL
11  2020 Concurrent cisplatin or cetuximab with radiotherapy for HPV-positive oropharyngeal cancer: Medical resource use, costs, and quality-adjusted survival from the De-ESCALaTE HPV trial. HPV, HRQoL, PT, QALYs
12  2020 Correlation between histogram-based DCE-MRI parameters and 18F-FDG PET values in oropharyngeal squamous cell carcinoma: Evaluation in primary tumors and metastatic nodes. DCE-MRI, HNSCC, LNs, MTV, PTs, SUV, TLG
13  2020 Deintensification of treatment for human papillomavirus-related oropharyngeal cancer: Current state and future directions. HPV
14  2020 Elevated TLR5 expression in vivo and loss of NF-kappaBeta activation via TLR5 in vitro detected in HPV-negative oropharyngeal squamous cell carcinoma. HaCaT, HPV, NF-kappaBeta, TLRs
15  2020 Engaging with Indigenous Australian communities for a human papilloma virus and oropharyngeal cancer project; use of the CONSIDER statement. ACCHOs
16  2020 Epithelial stem cell marker LGR6 expression identifies a low-risk subgroup in human papillomavirus positive oropharyngeal squamous cell carcinoma. DFS, HNSCC, HPV, LGRs, OS, RSPOs
17  2020 Epstein-Barr virus (EBV) and polyomaviruses are detectable in oropharyngeal cancer and EBV may have prognostic impact. BKV, DFS, EBER, EBV, HPV, JCV, OS, SV40
18  2020 Establishment of epigenetic markers to predict irradiation efficacy against oropharyngeal cancer. ---
19  2020 Evaluating the impact of smoking on disease-specific survival outcomes in patients with human papillomavirus-associated oropharyngeal cancer treated with transoral robotic surgery. HPV, RFS
20  2020 Evaluation of p16 as a surrogate marker for transcriptionally active human papillomavirus status of oropharyngeal squamous cell carcinoma in an eastern Chinese population. DSS, IHC, ISH, PCR
21  2020 Evaluation of the Anyplex II HPV28 Assay in the Detection of Human Papillomavirus in Archival Samples of Oropharyngeal Carcinomas. FFPE, HPV
22  2020 Factors associated with the quality of life for hospitalized patients with HPV-associated oropharyngeal squamous cell carcinoma. EAT-10, HPV, QOL
23  2020 Factors influencing patient and health care delays in Oropharyngeal Cancer. HPV, PHC, SC
24  2020 High nodal FDG uptake increases risk of distant metastasis in patients with oropharyngeal squamous cell carcinoma. HR
25  2020 HPV-related oropharyngeal cancer prevalence in a middle eastern population using E6/E7 PCR. PCR
26  2020 Human Papillomavirus Testing in Head and Neck Squamous Cell Carcinoma in 2020: Where Are We Now and Where Are We Going? HPV
27  2020 Impact of active smoking on outcomes in HPV+ oropharyngeal cancer. HPV, OS
28  2020 Impact of clinical complete response on treatment outcomes in patients with locally advanced HPV-negative oropharyngeal squamous cell carcinoma. cCR, CRT, HPV, S-IMRT, SIB-IMRT
29  2020 Impact of human papillomavirus status on survival and recurrence in a geographic region with a low prevalence of HPV-related cancer: A retrospective cohort study. AJCC, HPV
30  2020 Improving Oral Cancer Outcomes with Imaging and Artificial Intelligence. ---
31  2020 Knowledge Gaps among Patients and Providers in HPV-Related Oropharyngeal Cancer: A Systematic Review. HPV
32  2020 Lymph Node Ratio in HPV-Associated Oropharyngeal Cancer: Identification of a Prognostic Threshold. CI, HPV, HR, LNR
33  2020 Lymphatic mapping with SPECT-CT for evaluation of contralateral drainage in lateralized oropharyngeal cancers using an awake injection technique. ---
34  2020 Molecular mechanisms underlying increased radiosensitivity in human papillomavirus-associated oropharyngeal squamous cell carcinoma. HNSCC, HPV
35  2020 Multiple imputation and clinico-serological models to predict human papillomavirus status in oropharyngeal carcinoma: An alternative when tissue is unavailable. HPV, HPVsero
36  2020 Overexpression of HURP mRNA in head and neck carcinoma and association with in vitro response to vinorelbine. HURP
37  2020 Performance of AmpFire HPV assay on neck cervical lymph node aspirate and oropharyngeal samples. FNA, OPS
38  2020 Plasma Circulating Tumor HPV DNA for the Surveillance of Cancer Recurrence in HPV-Associated Oropharyngeal Cancer. CRT, ctHPVDNA, HPV, NPV, PPV
39  2020 Post-Treatment HPV Surface Brushings and Risk of Relapse in Oropharyngeal Carcinoma. HPV, HR
40  2020 Practice patterns and outcomes following radiation dose de-escalation for oropharyngeal cancer. HPV, RT
41  2020 Prognostic impact of PD-L1 in oropharyngeal cancer after primary curative radiotherapy and relation to HPV and tobacco smoking. aHR, CI, CPS, HPV
42  2020 Prognostic Significance of Smoking in Human Papillomavirus-Positive Oropharyngeal Cancer Under American Joint Committee on Cancer Eighth Edition Stage. CI, HPV, HRs, OS
43  2020 Skeletal muscle mass is an imaging biomarker for decreased survival in patients with oropharyngeal squamous cell carcinoma. DFS, OS, SMM
44  2020 Spatial proximity between T and PD-L1 expressing cells as a prognostic biomarker for oropharyngeal squamous cell carcinoma. HID
45  2020 Stage I HPV-positive oropharyngeal cancer: Should all patients receive similar treatments? AJCC, HPV, HR
46  2020 Stratification of HPV-associated and HPV-negative oropharyngeal squamous cell carcinomas based on DNA methylation epigenotypes. AUC, HPV, ROC
47  2020 Targeting Viral DNA and Promoter Hypermethylation in Salivary Rinses for Recurrent HPV-Positive Oropharyngeal Cancer. AUC, CI, HPV, OR, ROC
48  2020 The different role of PD-L1 in head and neck squamous cell carcinomas: A meta-analysis. CI, DFS, HNSCC, HR, OR, OS, OSCC, PD-L1
49  2020 The expression and prognostic impact of proinflammatory cytokines and their associations with carcinogens in oropharyngeal squamous cell carcinoma. HPV, IL-4, TSLP
50  2020 The role of tumour morphology in assigning HPV status in oropharyngeal squamous cell carcinoma. CAP, DSS, HPV, IHC, OS, SCCUP
51  2020 The virome of HPV-positive tonsil squamous cell carcinoma and neck metastasis. TORS
52  2020 Tonsillar p16-Positive Follicular Dendritic Cell Sarcoma Mimicking HPV-Related Oropharyngeal Squamous Cell Carcinoma: A Case Report and Review of Reported Cases. FDCS, HPV
53  2020 Transoral robotic surgery using the Medrobotic Flex system: the Adelaide experience. TORS
54  2020 Transoral robotic surgery: a 4-year learning experience in a single Danish Cancer Centre. CUP, HPV, TORS
55  2020 Tumor Subregion Evolution-Based Imaging Features to Assess Early Response and Predict Prognosis in Oropharyngeal Cancer. PFS
56  2019 A Hidden Epidemic of "Intermediate Risk" Oropharynx Cancer. HPV
57  2019 A systematic review of the HPV-attributable fraction of oropharyngeal squamous cell carcinomas in Germany. HPV, HPV-AF
58  2019 Advances in Diagnosis and Multidisciplinary Management of Oropharyngeal Squamous Cell Carcinoma: State of the Art. AJCC, HPV, IMRT, RT
59  2019 Advances in the Management of HPV-Related Oropharyngeal Cancer. ---
60  2019 Antitumour effects of metformin and curcumin in human papillomavirus positive and negative head and neck cancer cells. HNSCC, HPV
61  2019 Association between oropharyngeal cancers with known HPV and p16 status and cervical intraepithelial neoplasia: a Danish population-based study. CC, HPV
62  2019 Association of human papillomavirus related squamous cell carcinomas of the oropharynx and cervix. CC, HPV, SIR
63  2019 Carcinoma-associated Fibroblasts are a Common Finding in the Microenvironment of HPV-positive Oropharyngeal Squamous Cell Carcinoma. alpha-SMA, CAFs, HPV
64  2019 Characterization and radiosensitivity of HPV-related oropharyngeal squamous cell carcinoma patient-derived xenografts. HPV, PDX
65  2019 Characterization of the tumor immune micromilieu and its interference with outcome after concurrent chemoradiation in patients with oropharyngeal carcinomas. ICI, ISRS
66  2019 Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis. CISH, FFPE, HPV
67  2019 Chronic radiation-associated dysphagia in oropharyngeal cancer survivors: Towards age-adjusted dose constraints for deglutitive muscles. IMRT, RAD
68  2019 Clinical and Molecular Characterization of Surgically Treated Oropharynx Squamous Cell Carcinoma Samples. HPV, HR
69  2019 Clinical evaluation of tumour-infiltrating lymphocytes as a prognostic factor in patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma. DFS, HPV, OS, TIL
70  2019 Clinical value of transoral robotic surgery: Nationwide results from the first 5 years of adoption. HR, TLM, TLM, TORS
71  2019 Comorbidity in HPV+ and HPV- oropharyngeal cancer patients: A population-based, case-control study. CCI
72  2019 Comparative effectiveness of primary radiotherapy versus surgery in elderly patients with locally advanced oropharyngeal squamous cell carcinoma. BOT, CRT, ES, GD, MVA, ORN, OS, PS, RT
73  2019 Comparison of contemporary staging systems for oropharynx cancer in a surgically treated multi-institutional cohort. MDACC, RTOG, UICC
74  2019 Comparison of psychosocial factors over time among HPV+ oropharyngeal cancer and tobacco-related oral cavity cancer patients. HPV, OCSCC
75  2019 Correlation between plan quality improvements and reduced acute dysphagia and xerostomia in the definitive treatment of oropharyngeal squamous cell carcinoma. OARs, SS-IMRT, VMAT
76  2019 Correlation between the duration of locoregional control and survival in T1-T2 oropharyngeal cancer patients. OS
77  2019 Current Role of Surgery in the Management of Oropharyngeal Cancer. CRT, TLM, TORS
78  2019 Current status of human papillomavirus positivity in oropharyngeal squamous cell carcinoma in Europe: a systematic review. HPV
79  2019 Cyclo-oxygenase-2 Expression Is Associated With Lymph Node Metastasis in Oropharyngeal Squamous Cell Carcinoma Under the New TNM Classification. ---
80  2019 De-escalation of post-treatment surveillance in oropharyngeal cancer. ---
81  2019 Deintensification of Adjuvant Treatment After Transoral Surgery in Patients With Human Papillomavirus-Positive Oropharyngeal Cancer: The Conception of the PATHOS Study and Its Development. CRT, HPV, RCT, RT, TOS
82  2019 Development and Assessment of a Novel Composite Pathologic Risk Stratification for Surgically Resected Human Papillomavirus-Associated Oropharyngeal Cancer. HNSCC
83  2019 Differential Activation of ERK Signaling in HPV-Related Oropharyngeal Squamous Cell Carcinoma. HPV, TMAs
84  2019 Discrimination of HPV status using CT texture analysis: tumour heterogeneity in oropharyngeal squamous cell carcinomas. CECT, HPV, SD
85  2019 Does p16+ Predict a Favorable Prognosis for Oropharyngeal Cancer? Risk Factors for Treatment Failure for Patients Who Underwent Surgery-Based Therapy. AJCC, TORS
86  2019 Effects of tobacco abuse on major chromosomal instability in human papilloma virus 16-positive oropharyngeal squamous cell carcinoma. aCGH, HPV
87  2019 EGFR as a biomarker of smoking status and survival in oropharyngeal squamous cell carcinoma. ddPCR, DSS, TMAs
88  2019 Elemental Zn and its Binding Protein Zinc-alpha2-Glycoprotein are Elevated in HPV-Positive Oropharyngeal Squamous Cell Carcinoma. HNSCC, HPV, XFM, Zn
89  2019 Epidemiological trends of oropharyngeal and oral cavity squamous cell carcinomas in Northern New England, 2000-2013. APC, APC, ASIR, OCSCC
90  2019 Gastrostomy utilization by oropharyngeal cancer patients is partially driven by swallowing function. DIGEST, HPV, MBSS, MDADI, MDADI, PFG
91  2019 Heterogeneity in the clinical presentation, diagnosis, and treatment initiation of p16-positive oropharyngeal cancer. FNA, HPV
92  2019 High levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) in the serum are associated with poor prognosis in HPV-negative squamous cell oropharyngeal cancer. DFS, MMP-8, OS, TIMP-1
93  2019 HLA class II expression on tumor cells and low numbers of tumor-associated macrophages predict clinical outcome in oropharyngeal cancer. DFS, HLA, HPV, PD-L1, PD1, TAMs
94  2019 HPV as a marker for molecular characterization in head and neck oncology: Looking for a standardization of clinical use and of detection method(s) in clinical practice. FFPE, HPV
95  2019 HPV circulating tumoral DNA quantification by droplet-based digital PCR: A promising predictive and prognostic biomarker for HPV-associated oropharyngeal cancers. AJCC, ddPCR, HPV ctDNA, HR-HPV
96  2019 HPV detection and genotyping of head and neck cancer biopsies by molecular testing with regard to the new oropharyngeal squamous cell carcinoma classification based on HPV status. AJCC, AP28, FFPE, IL, WHO/IARC
97  2019 HPV Status Improves Classification of Head and Neck Gray Zone Cancers. HNSCC, HPV, ICD, OSCC
98  2019 HPV-driven oropharyngeal squamous cell cancer in Croatia - Demography and survival. FFPE, HNSCC, HPV
99  2019 Human papillomavirus and oral and oropharyngeal carcinoma: the essentials. HPV, OSCC
100  2019 Human papillomavirus and p16 immunostaining, prevalence and prognosis of squamous carcinoma of unknown primary in the head and neck region. HPV, HR